Skip to main content
NIH funding notice RFA-DE-24-002

Understanding Persistent Oral Human Papillomavirus and Human Immunodeficiency Virus Co-infection and Its Role with Oropharyngeal Cancer Induction (R21 Clinical Trial Not Allowed)

Closed on July 24, 2023.

Posted
April 7, 2023
Close date
July 24, 2023
Activity codes
Not stated on the notice page
Institutes taking part
Not stated on the notice page

The notices it replaced

Its page was not saved, so the notices it replaced are not known.

Who won it before

Competing awards, new and renewals, since FY2014, under this notice and the notices it replaced.

Past awards
1
1 new
First-year cost
$272,640
Institutions
1
1 contact PI

Awards by fiscal year

Fiscal years 2014 to 2026.

Most frequent institutions

  1. TULANE UNIVERSITY OF LOUISIANA1

Most frequent study sections

  1. Special Emphasis Panel (ZDE1 CC (10))1
1 award under RFA-DE-24-002 and the notices it replaced
FYProjectPIsInstitutionFirst-year costStudy section
FY2024Development of a Rhesus Macaque Model of Persistent Oral HPV and HIV Co-infection to Study Oropharyngeal Cancer Induction1R21DE033875-01Datta, Prasun KTraina-Dorge, Vicki LTULANE UNIVERSITY OF LOUISIANA, LAFirst-year cost $272,640Study section ZDE1
Newest fiscal year first, then first-year cost.

Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-14-0.3.3. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.

ScienceDex for departments

Open NIH notices that fit your faculty

See which open NIH funding notices fit each faculty member's CV, why each fits, and who won before.